After allowing the human clinical trial of the indigenous vaccine Covaxin and ZyCov-D for the corona virus in India, the government said it was 'the beginning of the end of the corona'.

The Union Ministry of Science and Technology in India has said in its letter that more than 100 vaccines are being tested all over the world and only 11 of them are undergoing human trials.

"The human trials of the vaccine will begin after getting permission from the Drug Controller General of India, which is the beginning of an end," the ministry letter said.

Six Indian companies are working on the Kovid-19 vaccine. Out of 140 vaccines across the world, 11 are undergoing human trials including two Indian vaccines Covaxin and ZyCov-D.

Usually the first two stages of a drug test are about safety while the third phase is about the effect of the drug.

Each phase can take months to years to complete.

The letter from the ministry came at a time when there was a dispute over deciding the last date of release of the ICMR vaccine to 15 August.

However, ICMR has now made it clear that the vaccine will come on the market only on the basis of global regulations.

Among the two indigenous vaccines that have been allowed to undergo human trials in India are Covaxin of Bharat Biotech and ZyCov-D of Zaedus Cadila.

Permission for first and second phase testing was received this week.

(Click here for Android APP of IBTN. You can follow us on facebook and Twitter)

Share This News

About sharing